Inovio Pharmaceuticals Stock Price - INO

0.29 (3.86%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Inovio Pharmaceuticals Inc New INO NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.29 3.86% 7.81 7.2401 7.9407 7.31 7.52 14:14:42
Bid Price Ask Price Spread Spread % News
7.80 7.81 0.01 0.13% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
43,621 8,132,666 $ 7.60 $ 61,841,714 48,190,227 1.915 - 19.00
Last Trade Time Type Quantity Stock Price Currency
14:14:42 100 $ 7.81 USD

Inovio Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.13B 145.80M $ -96.97M -1.23 - 140.48M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Inovio Pharmaceuticals News

Loading Messages....

Latest INO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical INO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week7.279.467.097.9421,247,3510.547.43%
1 Month10.8119.005.139.2244,632,800-3.00-27.75%
3 Months3.1819.003.047.8029,453,6954.63145.6%
6 Months2.0619.002.007.6314,069,5145.75279.13%
1 Year3.7219.001.9157.367,482,8814.09109.95%
3 Years6.6319.001.9156.893,316,8711.1817.8%
5 Years8.7019.001.9157.102,504,159-0.89-10.23%

Inovio Pharmaceuticals Description

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.